Investment
Features
FeesSafety
Academy
More
Pluang+

Compare e l f Beauty Inc (ELF) vs Zoetis Inc (ZTS) Price & Performance

e l f Beauty IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

e l f Beauty Inc vs Zoetis Inc — how do they compare? e l f Beauty Inc trades at $76.01 (market cap $4.37B), while Zoetis Inc trades at $77.02 (market cap $31.25B). The key difference: Zoetis Inc is far larger — about 7.2× e l f Beauty Inc's market cap, and Zoetis Inc pays a 2.84% dividend while e l f Beauty Inc pays none. Which is the better fit depends on your goals.

ELFZTS
Market Cap
$4.37B$31.25B
Sector
TechnologyHealth
52-Week High
$146.67$156.76
52-Week Low
$49.57$71.91
Enterprise Value
$5.00B$38.54B
Dividend Yield
2.84%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

e l f Beauty Inc

ELF Beauty trades at $76.11, up 5.34% with bullish technical signals and strong earnings beats. The stock shows robust revenue growth reaching $1.31B in 2025, though net margins remain thin at 1.61%. Recent analyst coverage is mixed with 46% buy ratings and consensus target of $74.42, slightly below current price. The company demonstrates solid operational cash flow of $133.84M and maintains a healthy balance sheet with $148.69M cash.

Outlook remains positive with continued double-digit sales growth targets, though elevated P/E ratio of 168.68 presents valuation concerns. Key risks include tariff exposure and core brand momentum challenges. Institutional sentiment leans bullish with recent price momentum supported by earnings outperformance and strategic expansion into skincare categories.

Zoetis Inc

ZTS trades at $74.08, down 1.74% on the day, with a bearish technical signal from moving averages. The company reported strong 2025 results including $9.47B revenue, $2.67B net income, and a 28.03% net margin, but missed Q1 2026 EPS estimates. Recent news highlights a securities class action lawsuit and the launch of Lenivia in Canada and the EU.

Despite near-term legal overhangs and a recent earnings miss, ZTS maintains robust profitability and a consensus price target of $101.43 implies significant upside. Key risks include litigation outcomes and competitive pressures in the companion animal segment, while solid cash flow and high ROE support long-term value.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About e l f Beauty Inc

e.l.f. Beauty is a leading cosmetics company offering high-quality, 100% vegan, and cruelty-free products. It is known for its affordable and prestige-quality makeup and skincare items for a diverse global audience.

Read more on ELF

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS